Research graph
References from Impact of adjuvant transarterial chemoembolization on survival following hepatectomy for subcapsular hepatocellular carcinoma: A propensity score-matched study. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 · External reference
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
10.1016/j.annonc.2025.02.006 · 2025 · External reference
Development and validation of nomograms to evaluate the survival outcome of HCC patients undergoing selective postoperative adjuvant TACE
10.1007/s11547-024-01792-0 · 2024 · External reference
Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection
10.7150/ijbs.46896 · 2020 · External reference
Development and validation of a CT-based online calculator for prognosis and postoperative adjuvant transcatheter arterial chemoembolization benefit prediction in resected hepatocellular carcinoma: a multicenter retrospective cohort study
2025 · External reference
Surgical margin affects the long-term prognosis of patients with hepatocellular carcinoma undergoing radical hepatectomy followed by adjuvant TACE
10.1093/oncolo/oyad088 · 2023 · External reference
Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
10.1186/s40880-018-0331-y · 2018 · External reference
Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study
10.1097/js9.0000000000000805 · 2024 · External reference
Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: a multicenter retrospective cohort
10.1002/ueg2.12365 · 2023 · External reference
Do hepatocellular carcinomas located in subcapsular space or in proximity to vessels increase the rate of local tumor progression? A meta-analysis
10.1016/j.lfs.2018.06.016 · 2018 · External reference
Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas ≤ 3 cm: analysis of long-term outcomes from two large-volume liver centers
10.1007/s00330-023-10165-6 · 2024 · External reference
Laparoscopic liver resection versus percutaneous radiofrequency ablation for small single nodular hepatocellular carcinoma: Comparison of treatment outcomes
10.1159/000510909 · 2021 · External reference
Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus nonsubcapsular hepatocellular carcinoma: a propensity score matched study
10.1148/radiol.2016151243 · 2016 · External reference
Analysis of t-test misuses and SPSS operations in medical research papers
10.1186/s41038-019-0170-3 · 2019 · External reference
Propensity score matching: the 'Devil is in the Details' where more may be hidden than you know
10.1016/j.amjmed.2019.08.055 · 2020 · External reference
Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration
10.7326/0003-4819-147-8-200710160-00010-w1 · 2007 · External reference
Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: a randomized, open-label, phase 3 trial
10.1097/hep.0000000000001233 · 2025 · External reference
Transarterial chemoembolization with radiofrequency ablation versus surgical resection for small late-recurrence hepatocellular carcinoma
10.1148/radiol.241096 · 2025 · External reference
Survival in patients with recurrent intermediate-stage hepatocellular carcinoma: Sorafenib plus TACE vs TACE alone randomized clinical trial
10.1001/jamaoncol.2024.1831 · 2024 · External reference
Triple adjuvant therapy with transarterial chemoembolizaition, lenvatinib, and programmed death-1 inhibitors improves short-term recurrence control in high-risk patients with resected intermediate-stage hepatocellular carcinoma
2025 · External reference
Impact of gas(less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases
10.1097/00000658-199612000-00005 · 1996 · External reference
